SLDB Latest Headlines

Solid Biosciences Showcases Next-Generation Gene Therapies with Key Data at 2026 MDA Conference

Market Chameleon (Mon, 9-Mar 11:19 AM)

Solid Biosciences Highlights Clinical Momentum in Gene Therapies Ahead of Key 2026 MDA Conference Presentation

Market Chameleon (Fri, 6-Mar 11:45 AM)

Solid Biosciences Lands $240 Million Oversubscribed Private Placement—Institutional Backing Fuels Ambitions in Genetic Medicine

Market Chameleon (Fri, 6-Mar 9:07 AM)

FDA Grants Orphan Drug Status to SLDB’s Novel Gene Therapy for Friedreich's Ataxia—What Does This Mean for Patients?

Market Chameleon (Tue, 13-Jan 8:38 AM)